Skip to main content

Table 3 Patients’ characteristics according to the expression of βcatenin

From: βcatenin is a marker of poor clinical characteristics and suppressed immune infiltration in testicular germ cell tumors

Variable    βcatenin
N Median interquartile range p-value Low High p-value
     N % N %  
All patients 247 100 150 NA 131 53 116 47  
Clinical subtype
 Pure seminoma 50 50 100 < 0.0001 42 84 8 16 < 0.0001
 Non-seminoma 197 200 115   89 45 108 55  
Tumor primary
 Testicular/retroperitoneal 245 100 150 0.035 131 53 114 47 0.131
 Mediastinal 2 300 N/A   0 0 2 100  
IGCCCG risk group
 Good 184 100 170 0.033 105 57 79 43 0.030
 Intermediate/Poor 63 200 130   26 42 37 58  
Number of metastatic sites
 0 63 100 100 0.408 32 51 31 49 0.813
 1 to 2 142 100 175   75 53 67 47  
  ≥ 3 42 100 142.5   24 57 18 43  
Retroperitoneal LN metastases
 Absent 72 130 100 0.075 36 50 36 50 0.540
 Present 175 100 175   95 54 80 46  
Mediastinal LN metastases
 Absent 215 100 150 0.598 117 54 98 46 0.260
 Present 32 200 168.75   14 44 18 56  
Lung metastases
 Absent 187 100 150 0.967 98 52 89 48 0.726
 Present 60 100 145   33 55 27 45  
Liver
 Absent 229 100 150 0.243 124 54 105 46 0.212
 Present 18 200 107.5   7 39 11 61  
Non-pulmonary visceral metastases
 Absent 225 100 150 0.891 120 53 105 47 0.765
 Present 22 150 150   11 50 11 50  
S – stage
 0–1 187 100 170 0.035 107 57 80 43 0.020
 2–3 60 200 130   24 40 36 60